This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04094/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04094/identifier/pubchem-compound/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB04094/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04094/identifier/drugbank/

Statements

Subject Item
n2:DB04094
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04094 n9:DB04094
dcterms:title
4-Hydroxy-2-Butanone
adms:identifier
n8:DB04094 n10:46508666 n12:BUQ n13:111509
n3:synthesisReference
Akinobu Matsuyama, Teruyuki Nikaido, Yoshinori Kobayashi, "Production of optically active 1,3-butanediol by asymmetric assimilation or reduction of 4-hydroxy-2-butanone." U.S. Patent US5219757, issued March, 1990.
n3:IUPAC-Name
n4:271B60BC-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B60C2-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B60C1-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B60BE-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B60BF-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B60C0-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B60BA-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B60BB-363D-11E5-9242-09173F13E4C5 n4:271B60B8-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B60B9-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B60C8-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B60C9-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B60C3-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B60C4-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B60C6-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B60C5-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B60C7-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B60CE-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B60D0-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B60D1-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B60CD-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B60CC-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B60CF-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B60BD-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B60CA-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B60CB-363D-11E5-9242-09173F13E4C5